Cardioprotective effects of the Na+/H+ exchange inhibitor cariporide in patients with acute anterior myocardial infarction undergoing direct PTCA

Circulation

Volumn 101, Issue 25, 2000, Pages 2902-2908

  Rupprecht, Hans Jürgen ^a   Vom Dahl, Jürgen ^b   Terres, Wolfram ^c   Seyfarth, Karl Melchior ^d   Richardt, Gert ^e   Schultheiß, Heinz Peter ^f   Buerke, Michael ^a   Sheehan, Florence H ^h   Drexler, Helmut ^g,i  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e University Clinic   (Germany)

^f University Clinic   (Germany)

^g University Clinic   (Germany)

^h UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

ⁱ HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Angioplasty; Cariporide; Myocardial infarction; Reperfusion; Sodium; Ventricles

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CALCIUM; CARIPORIDE; CREATINE KINASE; CREATINE KINASE MB; LACTATE DEHYDROGENASE; PLACEBO;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BOLUS INJECTION; CALCIUM TRANSPORT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; ENZYME ASSAY; FEMALE; HEART EJECTION FRACTION; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICULOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0034720844     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.25.2902     Document Type: Article

References (36)

1. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute MI: ISIS-2. Lancet. 1988;2:350-360.
2. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute MI. Lancet. 1986:1:397-402.
3. Weaver WD, Simes RJ, Betriu A, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute MI. JAMA. 1997;278:2093-2099.
4. Braunwald E, Kloner RA. Myocardial reperfusion: a double-edged sword? J Clin Invest. 1985;76:1713-1719.
5. + exchange. Am J Physiol. 1993;265(6 pt 2):H2017-H2026.
6. Ladzdunski M, Frelin C, Vigne P. The sodium/hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J Mol Cell Cardiol. 1985;17:1029-1042.
7. + concentration. J Biol Chem. 1984;259:8880-8885.
8. 2+ overload and impairs function in anoxic rat hearts. J Mol Cell Cardiol. 1990;22:57-72.
9. Scholz W, Albus U, Counillon L, et al. Protective effects of HOE 642, a selective sodium-hydrogen exchange subtype I inhibitor, on cardiac ischaemia and reperfusion. Cardiovasc Res. 1995;29:260-268.
10. Murphy E, Perlman M, London RE, et al. Amiloride delays the ischemia-induced rise in cytosolic free calcium. Circ Res. 1991;68: 1250-1258.
11. Meng H-P, Maddaford TG, Pierce GN. Effect of amiloride and selected analogues on postischemic recovery of contractile function. Am J Physiol. 1993;264(6 pt 2):H1831-H1835.
12. + antiporter isoforms using amiloride analogs and a new inhibitor exhibiting anti-ischemic properties. Mol Pharmacol. 1993;44:1041-1045.
13. + exchange inhibitors in cardiovascular therapy. Cardiovasc Res. 1995;29:184-188.
14. 2+ overload in isolated perfused rabbit heart. Circulation. 1994;89:2787-2798.
15. + exchange. Am J Physiol. 1988;255(3 pt 2): H608-H615.
16. + exchange inhibition in ischemic, reperfused porcine hearts. Circulation. 1995;92:912-917.
17. Gumina RJ, Mizumara T, Beier N, et al. A new sodium/hydrogen exchange inhibitor, EMD 85131, limits infarct size in dogs when administered before or after coronary artery occlusion. J Pharmacol Exp Ther. 1998;286:175-183.
18. Sheehan FH, Bolson EL, Dodge HT, et al. Advantages and applications of the centerline method for characterizing regional ventricular function. Circulation. 1986;74:293-305.
19. Dodge HT, Sandler H, Ballew DW, et al. The use of biplane angiocardiography for the measurement of LV volume in man. Am Heart J. 1960;60:762-776.
20. Guerci AD, Gerstenblinth G, Brinker JA, et al. A randomized trial of intravenous tissue plasminogen activator for acute MI with subsequent randomization to elective coronary angioplasty. N Engl J Med. 1987;317: 1613-1618.
21. Buerke M, Murohara T, Lefer AM. Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion. Circulation. 1995;91:393-402.
22. Entman ML, Smith CW. Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease. Cardiovasc Res. 1994;28:1301-1311.
23. Smalling RW, Feld S, Ramanna N, et al. Infarct salvage with liposomal prostaglandin E1 administered by intravenous bolus immediately before reperfusion in a canine infarction-reperfused model. Circulation. 1995;92:935-943.
24. Flaherty JT, Bertram P, Gruber JW, et al. Recombinant human superoxide dismutase/h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute MI. Circulation. 1994;89:1982-1991.
25. + exchange inhibitor, Hoe 642: difference from preconditioning in the role of protein kinase C. J Am Coll Cardiol. 1997;29:693-701.
26. + exchange inhibitor reduces infarct size in pigs. Cardiovasc Res. 1995;30:945-951.
27. Docherty JC, Yang L, Pierce GN, et al. Na (+)-H+ exchange inhibition at reperfusion is cardioprotective during myocardial ischemia-reperfusion: 31 NMR studies. Mol Cell Biochem. 1997;176:257-264.
28. + exchange immediately during reperfusion. Am J Physiol. 1997;273(5 pt 21):H2232-H2239.
29. Baller ID, Bretschneider HJ, Hellige G. Validity of myocardial oxygen consumption parameters. Clin Cardiol. 1979;2:317-327.
30. Sheehan FH, Doerr R, Schmidt WG, et al. Early recovery of LV function after thrombolytic therapy for acute MI: an important determinant of survival. J Am Coll Cardiol. 1988;12:289-300.
31. Pfeffer MA, Braunwald E. Ventricular remodeling after MI: experimental observations and clinical implication. Circulation. 1990;81:1161-1172.
32. Yamazaki T, Komuro I, Kudoh S, et al. Role of ion channels and exchangers in mechanical stretch-induced cardiomyocyte hypertrophy. Circ Res. 1998;82:430-437.
33. + exchange blocker amiloride on LV remodeling after anterior MI in rats. Cardiovasc Drugs Ther. 1995;9:823-826.
34. Sheehan FH, Braunwald E, Canner P, et al. The effect of intravenous thrombolytic therapy on LV function: a report on tissue plasminogen activator and streptokinase from the thrombolysis in MI (TIMI Phase I) trial. Circulation. 1987;75:817-829.
35. Linz W, Albus U, Crause P, et al. Dose-dependent reduction of myocardial infarct mass in rabbits by the NHE-1 inhibitor cariporide (HOE 642). Clin Exp Hypertens. 1998;20:733-749.
36. Bolli R. Myocardial "stunning" in man. Circulation. 1992;86:1671-1691.